No Data
No Data
Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
Express News | Form 144 | Teva Pharmaceutical Industries(TEVA.US) Insider Proposes to Sell 6.09 Million in Common Stocks
Teva Pharmaceutical Industries Ltd. to Release Q4 and Full Year 2024 Financial Results on January 29, 2025
Teva Pharmaceutical Industries Options Spot-On: On December 20th, 113.39K Contracts Were Traded, With 981.61K Open Interest
US MOVERS&SHAKERS Dec 16-Dec 20, 2024
UBS Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $28
No Data